Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 11
2 Introduction 13
2.1 What Is This Report About? 13
2.2 Definitions
13
2.2.1 Endoscopy Devices 13
2.2.1.1 Flexible Endoscope 13
2.2.1.2 Rigid Endoscope 13
3 Healthcare Sector Review 14
3.1
Healthcare Sector Review 14
3.2 Healthcare Expenditure 14
3.3
Healthcare Infrastructure 15
3.4 Healthcare Policy 16
4 Endoscopy
Devices in United Kingdom 18
4.1 Endoscopy Devices Overall Revenues
(2000-2012) 18
4.2 Endoscopy Devices Overall Volume (2000-2012) 24
4.3
Endoscopy Devices Overall Company Share (2006-2007) 27
5 Flexible
Endoscope in United Kingdom 28
5.1 Flexible Endoscope Overall Revenue
(2000-2012) 28
5.2 Flexible Endoscope Overall Volume (2000-2012) 30
5.3 Flexible Endoscope Average Price (2000-2012) 32
5.4 Flexible Endoscope
Distribution Share (2006-2007) 34
5.5 Flexible Endoscope Company Share
(2006-2007) 35
6 Rigid Endoscope in United Kingdom 36
6.1 Rigid
Endoscope Overall Revenues (2000-2012) 36
6.2 Rigid Endoscope Overall
Volume (2000-2012) 38
6.3 Rigid Endoscope Average Price (2000-2012) 40
6.4 Rigid Endoscope Distribution Share (2006-2007) 42
6.5 Rigid Endoscope
Company Share (2006-2007) 43
7 OLYMPUS CORPORATION Company Profile 44
7.1 Company Overview 44
7.2 Business Overview 44
7.2.1 Imaging Systems
Business 44
7.2.1.1 Overview 44
7.2.1.2 Financials 44
7.2.1.3
Capital Expenditure 44
7.2.1.4 Market View 44
7.2.1.5 Key Strategies
44
7.2.2 Information and Communication Business 45
7.2.2.1 Overview
45
7.2.2.2 Financials 45
7.2.2.3 Capital Expenditure 45
7.2.2.4
Key Strategies 45
7.2.3 Life Sciences Business 45
7.2.3.1 Overview
45
7.2.3.2 Financials 45
7.2.3.3 Capital Expenditure 45
7.2.3.4
Market View 46
7.2.3.5 Key Strategies 46
7.2.4 Medical Systems
Business 46
7.2.4.1 Overview 46
7.2.4.2 Financials 46
7.2.4.3
Capital Expenditure 46
7.2.4.4 Market View 46
7.2.4.5 Key Strategies
47
7.2.5 Others 47
7.2.5.1 Overview 47
7.2.5.2 Financials 47
7.2.5.3 Capital Expenditure 47
7.2.5.4 Market View 47
7.2.5.5 Key
Strategies 47
7.2.6 Major Products and Services 48
7.2.7 History
48
7.3 Value Chain Analysis 51
7.3.1 Manufacturing 51
7.3.1.1 In
House Manufacturing 51
7.3.2 Product Development 52
7.3.2.1 Regulatory
Approvals 52
7.3.2.2 Research and Development 52
7.3.3 Sales and
Marketing 52
7.3.3.1 Partnerships and Alliances 52
7.3.3.2 Licensing
Agreements 52
7.3.3.3 E-distribution 52
7.4 SWOT Analysis 53
7.4.1
OLYMPUS CORPORATION Strengths 53
7.4.1.1 Expansion of business activities
53
7.4.1.2 Strong internal control system 53
7.4.1.3 Strong financial
performance 54
7.4.2 OLYMPUS CORPORATION Weaknesses 54
7.4.2.1
Sluggish growth in Imaging Systems Business division 54
7.4.2.2 Weak
presence in Asia 54
7.4.2.3 Inconsistent profit margin 54
7.4.3
OLYMPUS CORPORATION Opportunities 54
7.4.3.1 Focused R&D 54
7.4.3.2
Launching of new products 55
7.4.3.3 Expansion of global markets 55
7.4.4 OLYMPUS CORPORATION Threats 55
7.4.4.1 Price competition 55
7.4.4.2 Dependent on key suppliers 55
7.4.4.3 Pricing pressures in Japan
56
7.5 Revenue Analysis 56
7.5.1 Revenue by Segment 56
7.5.2
Revenue by Geography 57
7.6 Financial and Operational Review 59
7.6.1
Financial Statements 59
7.6.2 Financial Ratios 60
7.6.3 Share Holding
Structure 61
7.7 Locations And Subsidiaries 62
7.8 OLYMPUS CORPORATION
Pipeline Products 64
7.8.1 OLYMPUS CAPSULE ENDOSCOPE SYSTEM 64
7.8.1.1
Product Overview 64
7.8.1.2 Product Description 64
7.8.1.3 Product
Status 64
7.8.2 Single Balloon Enteroscopy (SBE) system 64
7.8.2.1
Product Overview 64
7.8.2.2 Product Description 64
7.8.2.3 Product
Status 65
7.8.2.4 Product Milestone 65
8 KARL STORZ GmbH & Co. KG
Company Profile 66
8.1 Company Overview 66
8.2 Business Overview
66
8.2.1 Major Products and Services 66
8.2.2 History 67
8.3
Locations And Subsidiaries 68
9 PENTAX Medical Company Profile 70
9.1
Company Overview 70
9.2 Business Overview 70
9.2.1 Major Products and
Services 71
9.2.2 History 72
9.3 Locations And Subsidiaries 73
10
B. Braun Melsungen AG Company Profile 74
10.1 Company Overview 74
10.2
Business Overview 74
10.2.1 Aesculap division 74
10.2.1.1 Overview
74
10.2.1.2 Financials 74
10.2.1.3 Market View 74
10.2.1.4 Key
Strategies 74
10.2.2 B. Braun Avitum division 75
10.2.2.1 Overview
75
10.2.2.2 Financials 75
10.2.2.3 Market View 75
10.2.2.4 Key
Strategies 75
10.2.3 Hospital Care division 75
10.2.3.1 Overview
75
10.2.3.2 Financials 75
10.2.3.3 Key Strategies 75
10.2.4 Out
Patient Market (OPM) division 76
10.2.4.1 Overview 76
10.2.4.2
Financials 76
10.2.4.3 Market View 76
10.2.4.4 Key Strategies 76
10.2.5 Major Products and Services 76
10.2.6 History 77
10.3 Value
Chain Analysis 78
10.3.1 Manufacturing 78
10.3.1.1 In House
Manufacturing 78
10.3.1.2 Outsourcing 79
10.3.2 Product Development
79
10.3.2.1 Regulatory Approvals 79
10.3.2.2 Clinical Trials 79
10.3.2.3 Research and Development 80
10.3.3 Sales and Marketing 80
10.3.3.1 Partnerships and Alliances 80
10.3.3.2 Licensing Agreements
80
10.4 SWOT Analysis 81
10.4.1 B. Braun Melsungen AG Strengths 81
10.4.1.1 L.I.F.E certification 81
10.4.1.2 Significant revenues 81
10.4.1.3 Worldwide existence 82
10.4.2 B. Braun Melsungen AG Weaknesses
82
10.4.2.1 High SG&A expenses 82
10.4.2.2 FDA warning letter 82
10.4.3 B. Braun Melsungen AG Opportunities 82
10.4.3.1 Acquisitions 82
10.4.3.2 Expansion of business 83
10.4.3.3 Broad product portfolio 83
10.4.4 B. Braun Melsungen AG Threats 83
10.4.4.1 Foreign exchange 83
10.4.4.2 Intense competition and change in technologies 83
10.5 Revenue
Analysis 84
10.5.1 Revenue by Segment 84
10.5.2 Revenue by Geography
84
10.6 Financial and Operational Review 86
10.6.1 Financial
Statements 86
10.6.2 Financial Ratios 87
10.7 Locations And
Subsidiaries 88
10.8 B. Braun Melsungen AG Pipeline Products 90
10.8.1
Coroflex Please 90
10.8.1.1 Product Overview 90
10.8.1.2 Product
Description 90
10.8.1.3 Product Status 90
10.8.1.4 Product Milestone
91
10.8.2 SeQuent Please 92
10.8.2.1 Product Overview 92
10.8.2.2
Product Description 92
10.8.2.3 Product Status 92
11 Fujinon
Corporation Company Profile 95
11.1 Company Overview 95
11.2 Business
Overview 95
11.2.1 Major Products and Services 96
11.2.2 History
96
11.3 Locations And Subsidiaries 98
12 Regulation System 99
12.1
Medical Equipment Approval Process 99
12.1.1 Classification of Medical
Devices 99
12.1.2 Conformity Assessment Process 107
12.1.2.1 Class I
devices 108
12.1.2.2 Class IIa devices 109
12.1.2.3 Class IIb devices
110
12.1.2.4 Class III devices 111
12.2 Medical Device approval fee
111
12.3 Post Market Surveillance (PMS) 112
13 Pricing and
Reimbursement 113
13.1 Market Pricing 113
13.2 Government Policies for
Reimbursement 113
14 Distribution Structure 115
15 Appendix 116
15.1 Global Markets Direct Research Methodology 116
15.2 Coverage 117
15.3 Secondary Research 117
15.4 Primary Research 118
15.5 Models
118
15.6 Forecasts 119
15.7 Expert Panels 119
15.8 Currency
Conversion 120
15.9 Contact Us 121
15.10 Disclaimer 121
1.1
List of Tables
Table 1: Number of Doctor by Specialty in UK, 2003 - 2007
16
Table 2: Endoscopy Devices, United Kingdom, Overall Revenues ($ mn),
2000-2012 18
Table 3: Endoscopy Devices, United Kingdom, Overall Revenues
($ mn), Historic, 2000-2007 19
Table 4: Endoscopy Devices, United Kingdom,
Overall Revenues ($ mn), Forecast, 2007-2012 20
Table 5: Endoscopy
Devices, United Kingdom, Category Revenues ($ mn), 2000-2012 21
Table 6:
Endoscopy Devices, United Kingdom, Category Revenues ($ mn), Historic,
2000-2007 22
Table 7: Endoscopy Devices, United Kingdom, Category Revenues
($ mn), Forecast, 2007-2012 23
Table 8: Endoscopy Devices, United Kingdom,
Category Volume (Units), 2000-2012 24
Table 9: Endoscopy Devices, United
Kingdom, Category Volume (Units), Historic, 2000-2007 25
Table 10:
Endoscopy Devices, United Kingdom, Category Volume (Units), Forecast,
2007-2012 26
Table 11: Endoscopy Devices, United Kingdom, Company Share by
Revenue ($ mn), 2006-2007 27
Table 12: Flexible Endoscope, United Kingdom,
Overall Revenues ($ mn), Historic, 2000-2007 28
Table 13: Flexible
Endoscope, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012 29
Table 14: Flexible Endoscope, United Kingdom, Overall Volume (Units),
Historic, 2000-2007 30
Table 15: Flexible Endoscope, United Kingdom,
Overall Volume (Units), Forecast, 2007-2012 31
Table 16: Flexible
Endoscope, United Kingdom, Average Price ($), Historic, 2000-2007 32
Table
17: Flexible Endoscope, United Kingdom, Average Price ($), Forecast, 2007-2012
33
Table 18: Flexible Endoscope, United Kingdom, Distribution Share by
Revenue ($ mn), 2006-2007 34
Table 19: Flexible Endoscope, United Kingdom,
Company Share by Revenue ($ mn), 2006-2007 35
Table 20: Rigid Endoscope,
United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007 36
Table 21:
Rigid Endoscope, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
37
Table 22: Rigid Endoscope, United Kingdom, Overall Volume (Units),
Historic, 2000-2007 38
Table 23: Rigid Endoscope, United Kingdom, Overall
Volume (Units), Forecast, 2007-2012 39
Table 24: Rigid Endoscope, United
Kingdom, Average Price ($), Historic, 2000-2007 40
Table 25: Rigid
Endoscope, United Kingdom, Average Price ($), Forecast, 2007-2012 41
Table
26: Rigid Endoscope, United Kingdom, Distribution Share by Revenue ($ mn),
2006-2007 42
Table 27: Rigid Endoscope, United Kingdom, Company Share by
Revenue ($ mn), 2006-2007 43
Table 28: OLYMPUS CORPORATION, SWOT
Analysis, 2007 53
Table 29: OLYMPUS CORPORATION, Revenue by Segment,
Yen Million, 2003-2007 57
Table 30: OLYMPUS CORPORATION, Revenue by
Geography, Yen Million, 2003-2007 58
Table 31: OLYMPUS CORPORATION,
Financial Statements, Yen Million, 2003-2007 59
Table 32: OLYMPUS
CORPORATION, Financial Ratios, Yen Million, 2003-2007 60
Table 33:
OLYMPUS CORPORATION, Share Holding Structure 61
Table 34: OLYMPUS
CORPORATION, Other Locations 62
Table 35: OLYMPUS CORPORATION, Other
Locations(Contd..) 63
Table 36: OLYMPUS CORPORATION, Subsidiaries
63
Table 37: KARL STORZ GmbH & Co. KG, Other Locations 68
Table
38: KARL STORZ GmbH & Co. KG, Other Locations(Contd..) 69
Table 39:
PENTAX Medical Company, Other Locations 73
Table 40: B. Braun
Melsungen AG, SWOT Analysis, 2006 81
Table 41: B. Braun Melsungen AG,
Revenue by Segment, Euro Thousand, 2002-2006 84
Table 42: B. Braun
Melsungen AG, Revenue by Geography, Euro Thousand, 2002-2006 85
Table 43:
B. Braun Melsungen AG, Financial Statements, Euro Thousand, 2002-2006
86
Table 44: B. Braun Melsungen AG, Financial Ratios, Euro Thousand,
2002-2006 87
Table 45: B. Braun Melsungen AG, Subsidiaries 88
Table 46: B. Braun Melsungen AG, Subsidiaries(Contd..) 89
Table 47:
Fujinon Corporation, Subsidiaries 98
Table 48: Medical Device Approval
Fee in UK, 2006 112
Table 49: Currency Conversion from USD to Local
Currency at 2007 Constant Rate 120
1.2 List of Figures
Figure 1:
Total Healthcare Expenditure in UK, 2000 - 2006 15
Figure 2: Endoscopy
Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012 18
Figure 3:
Endoscopy Devices, United Kingdom, Overall Revenues ($ mn), Historic,
2000-2007 19
Figure 4: Endoscopy Devices, United Kingdom, Overall Revenues
($ mn), Forecast, 2007-2012 20
Figure 5: Endoscopy Devices, United
Kingdom, Category Revenues ($ mn), 2000-2012 21
Figure 6: Endoscopy
Devices, United Kingdom, Category Revenues ($ mn), Historic, 2000-2007 22
Figure 7: Endoscopy Devices, United Kingdom, Category Revenues ($ mn),
Forecast, 2007-2012 23
Figure 8: Endoscopy Devices, United Kingdom,
Category Volume (Units), 2000-2012 24
Figure 9: Endoscopy Devices, United
Kingdom, Category Volume (Units), Historic, 2000-2007 25
Figure 10:
Endoscopy Devices, United Kingdom, Category Volume (Units), Forecast,
2007-2012 26
Figure 11: Endoscopy Devices, United Kingdom, Company Share
(%), 2007 27
Figure 12: Flexible Endoscope, United Kingdom, Overall
Revenues ($ mn), Historic, 2000-2007 28
Figure 13: Flexible Endoscope,
United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012 29
Figure 14:
Flexible Endoscope, United Kingdom, Overall Volume (Units), Historic,
2000-2007 30
Figure 15: Flexible Endoscope, United Kingdom, Overall Volume
(Units), Forecast, 2007-2012 31
Figure 16: Flexible Endoscope, United
Kingdom, Average Price ($), Historic, 2000-2007 32
Figure 17: Flexible
Endoscope, United Kingdom, Average Price ($), Forecast, 2007-2012 33
Figure 18: Flexible Endoscope, United Kingdom, Distribution Share (%), 2007
34
Figure 19: Flexible Endoscope, United Kingdom, Company Share (%), 2007
35
Figure 20: Rigid Endoscope, United Kingdom, Overall Revenues ($ mn),
Historic, 2000-2007 36
Figure 21: Rigid Endoscope, United Kingdom, Overall
Revenues ($ mn), Forecast, 2007-2012 37
Figure 22: Rigid Endoscope, United
Kingdom, Overall Volume (Units), Historic, 2000-2007 38
Figure 23: Rigid
Endoscope, United Kingdom, Overall Volume (Units), Forecast, 2007-2012 39
Figure 24: Rigid Endoscope, United Kingdom, Average Price ($), Historic,
2000-2007 40
Figure 25: Rigid Endoscope, United Kingdom, Average Price
($), Forecast, 2007-2012 41
Figure 26: Rigid Endoscope, United Kingdom,
Distribution Share (%), 2007 42
Figure 27: Rigid Endoscope, United
Kingdom, Company Share (%), 2007 43
Figure 28: OLYMPUS CORPORATION, Value
Chain Analysis 51
Figure 29: B. Braun Melsungen AG, Value Chain Analysis
78
Figure 30: Flowchart for Classification of Non-invasive Devices in UK,
2007 100
Figure 31: Flowchart for Classification of Invasive Devices in
UK, 2007 101
Figure 32: Flowchart for Classification of Invasive Devices
in UK, 2007 102
Figure 33: Flowchart for Classification of Invasive
Devices in UK, 2007 103
Figure 34: Flowchart for Classification of
Invasive Devices in UK, 2007 104
Figure 35: Flowchart for Classification
of Active Devices in UK, 2007 105
Figure 36: Flowchart for Classification
of Active Devices in UK, 2007 106
Figure 37: Flowchart for Classification
of Devices except Non-invasive, Invasive and Active Devices in UK, 2007
107
Figure 38: Conformity Assessment of Class-I Medical Devices in UK,
2007 108
Figure 39: Conformity Assessment of Class-IIa Medical Devices in
UK, 2007 109
Figure 40: Conformity Assessment of Class-IIb Medical Devices
in UK, 2007 110
Figure 41: Conformity Assessment of Class-III Medical
Devices in UK, 2007 111
Figure 42: Global Markets Direct Methodology
116
View Cart
